Breakdown | ||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
16.79B | 16.15B | 15.95B | 13.89B | 12.68B | Gross Profit |
3.91B | 3.72B | 3.63B | 3.32B | 3.08B | EBIT |
624.67M | 627.16M | 752.83M | 605.68M | 474.75M | EBITDA |
697.54M | 706.17M | 830.57M | 679.53M | 467.25M | Net Income Common Stockholders |
399.13M | 410.62M | 481.56M | 423.52M | 236.98M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.08B | 1.51B | 929.59M | 920.99M | 937.74M | Total Assets |
5.75B | 6.52B | 6.47B | 5.52B | 5.52B | Total Debt |
0.00 | 61.67M | 349.25M | 33.54M | 437.20M | Net Debt |
-1.08B | -1.45B | -580.34M | -887.45M | -500.54M | Total Liabilities |
4.31B | 4.60B | 4.84B | 4.53B | 4.41B | Stockholders Equity |
1.44B | 1.91B | 1.63B | 990.35M | 1.11B |
Cash Flow | Free Cash Flow | |||
0.00 | 1.07B | -431.30M | 942.66M | -420.60M | Operating Cash Flow |
0.00 | 1.13B | -401.53M | 978.09M | -290.15M | Investing Cash Flow |
0.00 | -114.05M | -29.78M | -35.43M | -173.14M | Financing Cash Flow |
0.00 | -441.10M | 439.90M | -959.40M | 227.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥4.54B | 10.48 | 1.21% | 9.32% | 25.59% | ||
78 Outperform | ¥4.03B | 7.40 | 4.43% | 4.70% | 31.78% | ||
71 Outperform | ¥4.32B | 319.28 | ― | -2.43% | -78.05% | ||
69 Neutral | ¥3.98B | 11.54 | 1.64% | 17.68% | -31.19% | ||
63 Neutral | ¥4.12B | 18.69 | 4.04% | 9.26% | 1.71% | ||
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% | |
54 Neutral | ¥3.89B | 26.89 | ― | 30.73% | ― |